Stock RPH S.C. ROPHARMA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials S.C. Ropharma S.A.

Equities

RPH

ROIAFRACNOR4

Drug Retailers

End-of-day quote Bucharest S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.195 RON +4.84% Intraday chart for S.C. Ropharma S.A. +2.63% -2.50%
2023 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 188.1 178.9 140.6 117.2 106 95.61
Enterprise Value (EV) 1 212.1 237.2 274.2 248.6 232.2 228.5
P/E ratio 16.2 x 14.7 x 19.1 x 17.4 x - 10.4 x
Yield - - - - - -
Capitalization / Revenue 0.35 x 0.28 x 0.18 x 0.15 x 0.12 x 0.1 x
EV / Revenue 0.4 x 0.37 x 0.35 x 0.31 x 0.26 x 0.23 x
EV / EBITDA 9.61 x 11.2 x 14.5 x 9.92 x 7.4 x 9.45 x
EV / FCF -6.94 x 38.9 x -27.4 x -33.7 x -65.2 x 22.1 x
FCF Yield -14.4% 2.57% -3.65% -2.96% -1.53% 4.53%
Price to Book 1.17 x 1.03 x 0.79 x 0.59 x - 0.41 x
Nbr of stocks (in thousands) 511,267 511,267 498,499 509,742 509,736 511,267
Reference price 2 0.3680 0.3500 0.2820 0.2300 0.2080 0.1870
Announcement Date 4/26/18 4/25/19 4/30/20 4/28/21 4/28/22 4/27/23
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 534.8 636.2 783.7 805.9 888.2 1,002
EBITDA 1 22.06 21.23 18.89 25.06 31.36 24.18
EBIT 1 13.08 11.59 8.701 10.55 17.11 9.256
Operating Margin 2.45% 1.82% 1.11% 1.31% 1.93% 0.92%
Earnings before Tax (EBT) 1 15.21 14.76 6.689 6.637 13.53 10.32
Net income 1 11.63 12.12 7.523 6.753 10.73 9.216
Net margin 2.17% 1.9% 0.96% 0.84% 1.21% 0.92%
EPS 2 0.0227 0.0237 0.0148 0.0132 - 0.0180
Free Cash Flow 1 -30.58 6.104 -10 -7.366 -3.56 10.35
FCF margin -5.72% 0.96% -1.28% -0.91% -0.4% 1.03%
FCF Conversion (EBITDA) - 28.74% - - - 42.8%
FCF Conversion (Net income) - 50.36% - - - 112.29%
Dividend per Share - - - - - -
Announcement Date 4/26/18 4/25/19 4/30/20 4/28/21 4/28/22 4/27/23
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 23.9 58.2 134 131 126 133
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.085 x 2.743 x 7.076 x 5.241 x 4.022 x 5.496 x
Free Cash Flow 1 -30.6 6.1 -10 -7.37 -3.56 10.3
ROE (net income / shareholders' equity) 8.26% 7.17% 2.53% 2.37% 5.49% 3.31%
ROA (Net income/ Total Assets) 2.41% 1.71% 0.93% 1% 1.62% 0.8%
Assets 1 483.2 710.4 805.7 678.7 661.5 1,145
Book Value Per Share 2 0.3100 0.3400 0.3600 0.3900 - 0.4500
Cash Flow per Share 2 0.0200 0.0200 0.0200 0.0300 - 0.0300
Capex 1 17.1 16.4 27 12 17.6 10.4
Capex / Sales 3.2% 2.57% 3.44% 1.49% 1.99% 1.04%
Announcement Date 4/26/18 4/25/19 4/30/20 4/28/21 4/28/22 4/27/23
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs with Grocery

1st Jan change Capi.
S.C. ROPHARMA S.A. Stock S.C. Ropharma S.A.
-2.50% 21.39M
COSMOS PHARMACEUTICAL CORPORATION Stock COSMOS Pharmaceutical Corporation
-11.64% 3.62B
SUNDRUG CO.,LTD. Stock Sundrug Co.,Ltd.
-0.09% 3.36B
TSURUHA HOLDINGS INC. Stock Tsuruha Holdings Inc.
-23.44% 3.06B
LBX PHARMACY CHAIN Stock LBX Pharmacy Chain
+7.46% 2.59B
KUSURI NO AOKI HOLDINGS CO., LTD. Stock Kusuri No Aoki Holdings Co., Ltd.
-9.26% 1.75B
CREATE SD HOLDINGS CO., LTD. Stock Create SD Holdings Co., Ltd.
+9.30% 1.35B
GREAT TREE PHARMACY CO., LTD. Stock Great Tree Pharmacy Co., Ltd.
-20.60% 957M
SHUYU CIVILIAN PHARMACY CORP., LTD. Stock ShuYu Civilian Pharmacy Corp., Ltd.
-38.42% 704M
FARMACIAS BENAVIDES, S.A.B. DE C.V. Stock Farmacias Benavides, S.A.B. de C.V.
-0.53% 450M
Retail - Drugs with Grocery
  1. Stock Market
  2. Equities
  3. RPH Stock
  4. Financials S.C. Ropharma S.A.